SEC Form 4 · accession 0001179110-15-003548
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
W Gerald Austen
Director
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 7:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF1 | Feb 24, 2015 | S | 6,000 | $60.6212 | D | 83,341 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $60.6143 and $60.82. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the issuer.